| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2016PLoSO..1155382D |
| P356 | DOI | 10.1371/JOURNAL.PONE.0155382 |
| P932 | PMC publication ID | 4873138 |
| P698 | PubMed publication ID | 27195985 |
| P50 | author | Garth D Ehrlich | Q46488825 |
| P2093 | author name string | Wen Zhong | |
| Jeffrey M Jacobson | |||
| Brian Wigdahl | |||
| Michael R Nonnemacher | |||
| Will Dampier | |||
| Shendra Passic | |||
| Vanessa Pirrone | |||
| Joshua Mell | |||
| Jean W Williams | |||
| Katherine Kercher | |||
| Benjamas Aiamkitsumrit | |||
| Joshua Earl | |||
| P2860 | cites work | MUSCLE: multiple sequence alignment with high accuracy and high throughput | Q24613456 |
| HIV Drug Resistance: Problems and Perspectives | Q26864534 | ||
| Viral quasispecies evolution | Q27013917 | ||
| HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities | Q27015965 | ||
| Bioinformatic analysis of HIV-1 entry and pathogenesis | Q27693321 | ||
| Timing the ancestor of the HIV-1 pandemic strains | Q28137904 | ||
| RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies | Q28658397 | ||
| BEAST 2: a software platform for Bayesian evolutionary analysis | Q28660145 | ||
| jModelTest 2: more models, new heuristics and parallel computing | Q29546516 | ||
| DendroPy: a Python library for phylogenetic computing | Q29614993 | ||
| Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection | Q29619510 | ||
| Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase | Q29619994 | ||
| The analysis of multivariate longitudinal data: a review. | Q51377078 | ||
| The greater than twofold cost of integration for retroviruses. | Q55077455 | ||
| HIV-1-associated central nervous system dysfunction | Q30615171 | ||
| Challenges in HIV Vaccine Research for Treatment and Prevention | Q34148683 | ||
| Defining differential genetic signatures in CXCR4- and the CCR5-utilizing HIV-1 co-linear sequences | Q34267043 | ||
| Development of co-selected single nucleotide polymorphisms in the viral promoter precedes the onset of human immunodeficiency virus type 1-associated neurocognitive impairment | Q34671618 | ||
| Introduction: challenges to finding a cure for HIV infection | Q34802250 | ||
| HIV1 and the gut in the era of highly active antiretroviral therapy | Q34848194 | ||
| HIV-1 Tat alters neuronal autophagy by modulating autophagosome fusion to the lysosome: implications for HIV-associated neurocognitive disorders | Q35044780 | ||
| Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmission | Q35488153 | ||
| HIV-1 subtypes B and C Tat differentially impact synaptic plasticity expression and implicates HIV-associated neurocognitive disorders | Q36010129 | ||
| Variability of HIV infections | Q36274670 | ||
| Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection | Q36647820 | ||
| Emergence in Japan of an HIV-1 variant associated with transmission among men who have sex with men (MSM) in China: first indication of the International Dissemination of the Chinese MSM lineage | Q36827255 | ||
| HIV rebounds from latently infected cells, rather than from continuing low-level replication | Q36954950 | ||
| Cellular reservoirs of HIV-1 and their role in viral persistence | Q37196089 | ||
| Minority report: hidden memory genomes in HIV-1 quasispecies and possible clinical implications. | Q37211736 | ||
| Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection | Q37273158 | ||
| The challenge of finding a cure for HIV infection | Q37407598 | ||
| The HIV hide and seek game: an immunogenomic analysis of the HIV epitope repertoire | Q37529024 | ||
| Where does HIV hide? A focus on the central nervous system | Q37590425 | ||
| The number and genetic relatedness of transmitted/founder virus impact clinical outcome in vaginal R5 SHIVSF162P3N infection | Q37683788 | ||
| Skyline-plot methods for estimating demographic history from nucleotide sequences | Q37863752 | ||
| Viral fitness: definitions, measurement, and current insights | Q38044156 | ||
| Evolution of HIV integrase resistance mutations. | Q38067599 | ||
| Tracking replication-competent HIV reservoirs in infected individuals | Q38079096 | ||
| Reactivation of latent HIV by histone deacetylase inhibitors. | Q38091753 | ||
| Selective recognition of viral promoters by host cell transcription complexes: challenges and opportunities to control latency | Q38119329 | ||
| Establishment and molecular mechanisms of HIV-1 latency in T cells | Q38129514 | ||
| Genome editing-based HIV therapies | Q38323887 | ||
| Human Immunodeficiency Virus Type 1 Cellular Entry and Exit in the T Lymphocytic and Monocytic Compartments: Mechanisms and Target Opportunities During Viral Disease | Q38537922 | ||
| Analysis of human lung endothelial cells for susceptibility to HIV type 1 infection, coreceptor expression, and cytotoxicity of gp120 protein | Q39119649 | ||
| HIV Type 1 transmission networks among men having sex with men and heterosexuals in Kenya | Q41906976 | ||
| The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time | Q41954397 | ||
| Evolution of human immunodeficiency virus type 1 envelope sequences in infected individuals with differing disease progression profiles. | Q45757502 | ||
| HIV-1 genomic RNA diversification following sexual and parenteral virus transmission | Q45873185 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | genetic variation | Q349856 |
| viral quasispecies | Q104765291 | ||
| P304 | page(s) | e0155382 | |
| P577 | publication date | 2016-05-19 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | HIV-1 Genetic Variation Resulting in the Development of New Quasispecies Continues to Be Encountered in the Peripheral Blood of Well-Suppressed Patients | |
| P478 | volume | 11 |
| Q47170193 | Bayesian estimation of scaled mutation rate under the coalescent: a sequential Monte Carlo approach |
| Q89399006 | Broad-Spectrum and Personalized Guide RNAs for CRISPR/Cas9 HIV-1 Therapeutics |
| Q52430698 | CRISPR/Cas9 and Genome Editing for Viral Disease-Is Resistance Futile? |
| Q90999537 | Compartmentalized evolution of Bovine Viral Diarrhoea Virus type 2 in an immunotolerant persistently infected cow |
| Q54225233 | Defining the molecular mechanisms of HIV-1 Tat secretion: PtdIns(4,5)P2 at the epicenter. |
| Q99237752 | Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing |
| Q43212335 | Designing broad-spectrum anti-HIV-1 gRNAs to target patient-derived variants. |
| Q33768060 | Evidence of Divergent Amino Acid Usage in Comparative Analyses of R5- and X4-Associated HIV-1 Vpr Sequences |
| Q92135927 | Genetic variation and function of the HIV-1 Tat protein |
| Q91711649 | HIV-1 Tat Length: Comparative and Functional Considerations |
| Q92775396 | Investigating the distribution of HIV-1 Tat lengths present in the Drexel Medicine CARES cohort |
| Q91344642 | Novel gRNA design pipeline to develop broad-spectrum CRISPR/Cas9 gRNAs for safe targeting of the HIV-1 quasispecies in patients |
| Q90298967 | Prediction of Human Immunodeficiency Virus Type 1 Subtype-Specific Off-Target Effects Arising from CRISPR-Cas9 Gene Editing Therapy |
| Q40618199 | Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status. |
| Q90395045 | The Determination of HIV-1 RT Mutation Rate, Its Possible Allosteric Effects, and Its Implications on Drug Resistance |
| Q55654521 | Viral diversity is an obligate consideration in CRISPR/Cas9 designs for targeting the HIV reservoir. |
Search more.